Spec. MD. Emin Oğuz
Internal Medicine
Spec. Dr. Emin Oğuz – Leading Internal Medicine and Rheumatology Expert with Advanced Clinical and Research Excellence
Spec. Dr. Emin Oğuz is a distinguished specialist in internal medicine and rheumatology at İstinye University Hospital, recognized for his dedication to delivering patient-centric, evidence-based care for complex autoimmune and systemic diseases. After completing his medical education at Uludağ University, Dr. Oğuz pursued a comprehensive residency in internal medicine at Istanbul University Medical Faculty, further specializing in the Division of Rheumatology.
His clinical expertise spans a wide spectrum of rheumatologic conditions, including idiopathic inflammatory myopathies such as dermatomyositis, polymyositis, and immune-mediated necrotizing myopathy, as well as systemic lupus erythematosus, scleroderma, vasculitis, including Behçet’s disease, IgG4-related disease, rheumatoid arthritis, and ankylosing spondylitis. Committed to delivering world-class care, he integrates advanced diagnostic tools and minimally invasive treatment strategies to ensure optimal outcomes, faster recovery, and the highest level of patient comfort.
Throughout his career, Dr. Oğuz has cultivated a patient-focused approach that emphasizes individualized care tailored to each patient’s specific condition and circumstances. He prioritizes clear communication and collaborative decision-making with patients and their families, fostering trust and confidence while ensuring adherence to evidence-based treatment protocols.
His practice reflects a careful balance of clinical expertise, modern technology, and compassionate care, enabling him to manage complex cases with precision and efficiency. Dr. Oğuz is highly regarded for his ability to address rare and challenging rheumatologic conditions while maintaining a supportive and empathetic clinical environment.
In addition to his clinical work, Dr. Oğuz is an active researcher and academic contributor in the field of rheumatology. His publications include studies on Behçet’s disease, amyloidosis, idiopathic inflammatory myopathies, and novel therapeutic approaches such as TNF inhibitors and IL-1 therapies. He has contributed to numerous peer-reviewed journals, reflecting his commitment to advancing scientific knowledge and improving patient outcomes through rigorous research. His scholarly work demonstrates expertise in evidence-based medicine and highlights his role as a mentor and academic authority guiding future physicians in internal medicine and rheumatology.
Dr. Oğuz’s integration of clinical excellence, patient-centered care, and scientific leadership defines his professional identity. His dedication ensures that patients receive not only effective treatment but also holistic care that supports long-term health and quality of life. Known for his meticulous approach, profound expertise, and compassionate patient interactions, Spec. Dr. Emin Oğuz represents the highest standard of modern internal medicine and rheumatology, providing world-class care that addresses both the complexities of disease and the individual needs of each patient.
E Oguz, M Bektaş - JCR: Journal of Clinical Rheumatology, 2023 - journals.lww.com
M Bektas, N Koca, E Oguz, S Sari, G Dagci… - …, 2024 - academic.oup.com
- The safety and efficacy of TNF inhibitors in patients with Behçet's disease: Retrospective study from eastern Turkey M Bektaş, MD Özer, E Oğuz - Clinical Immunology, 2024 – Elsevier
- Amiloid yaygınlığı ve ilişkili faktörler Ailevi Akdeniz ateşi ilişkili amiloiozda kötü prognoz ve yüksek mortaliteyi öngördürür: Yüz otuz yedi hastanın verisi.
M Bektaş, N Koca, E Oğuz, B İnce… - Journal of Turkish …, 2022 - search.ebscohost.com
M Bektaş, EG Işık, E Oğuz, F Kemik… - Clinical and …, 2024 - researchgate.net
B Toz, S Tacar, E Oguz, M Erdugan, BA Esen, S Kamali… - 2016 - ard.bmj.com
AB Dirim, S Mirioglu, N Yesilot, E Oguz… - Journal of Clinical …, 2022 - Wiley Online Library
A Acar, D Bulut, S Çelik, E Oğuz - Klimik Journal/Klimik …, 2022 - klimikdergisi.org
- AA amiloidozlu hastalarda amiloid fırtınası artmış amiloid yükü ve yüksek mortalite ile ilişkilidir.
M Bektaş, S Sarı, N Koca, E Oğuz… - Journal of Turkish …, 2022 - search.ebscohost.com
Classification of Idiopathic Inflammatory Myopathies: Assessment of 123 Patients According to 2017 Acr/EULAR Criteria Followed up By a Single Center from E Oguz - 2018 ACR/ARHP Annual Meeting, 2018 – ACR
…, G Dağcı, S Aghamuradov, Ç Çetin, ML Öçal, E Oğuz… - acikerisim.istanbul.edu.tr
- Favourable Response to Rituximab for the Treatment of IgG4-Related Disease: Long-Term Follow-up of 10 Patients Resistant to Glucocorticoids and …
E Oguz - 2018 ACR/ARHP Annual Meeting, 2018 – ACR
Long-Term Effıcacy And Safety Of Tnf Inhıbıtors In Patıents Wıth Ankylosıng Spondylıtıs: A Sıngle Centre Experıence.T Bahtiyar, E Murat, O Emin… - INTERNAL …, 2016 - … ST, HOBOKEN 07030-5774, NJ USA
A Gül, M Kurtuncu, M Erdugan, E Oguz, T Gunduz… - 2020 - ard.bmj.com